Use of avian retroviral vectors to introduce transcriptional regulators into mammalian cells for analyses of tumor maintenance

A key issue in cancer biology is whether genetic lesions involved in tumor initiation or progression are required for tumor maintenance. This question can be addressed with mouse models that conditionally express oncogenic transgenes, i.e., under the control of tetracycline (tet)-dependent transcriptional regulators. We have developed a system for studying tumor maintenance by using avian retroviral [i.e., replication-competent avian leukosis virus long terminal repeat with splice acceptor (RCAS)] vectors to deliver the reverse tet transcriptional transactivator (rtTA) gene to somatic mammalian cells. rtTA can regulate any transgene in which the protein coding sequence is preceded by a tet-operator (tet-o); RCAS viruses infect only cells engineered to express ectopically the avian retroviral receptor, TVA. One vector, RCAS-rtTA-IRES-GFP, also encodes GFP to identify infected cells. Infection of cells from β-actin TVA transgenic mice with this vector permits efficient regulation of tet-responsive transgenes. Sarcomas arise when p53-deficient murine embryonic fibroblasts carrying β-actin TVA and tet-o-K-ras4bG12D transgenes are infected with RCAS-rtTA-IRES-GFP and introduced into nude mice treated with the tet analog, doxycycline (dox); when dox is withdrawn, K-ras4bG12D levels fall, cells undergo apoptosis, and tumors regress. Regression can be prevented by means of a genetic complementation assay in which tumors are superinfected before dox withdrawal with other RCAS viruses, such as those carrying an active allele of K-ras. Many TVA and tet-regulated transgenic mice have been generated; thus, this method for somatic cell-specific and temporally controlled gene expression may have broad applications for the study of oncogenesis and tumor maintenance, as well as other cell functions and development.

[1]  Dean W. Felsher,et al.  Cancer revoked: oncogenes as therapeutic targets , 2003, Nature Reviews Cancer.

[2]  S. Orsulic.  An RCAS-TVA-based approach to designer mouse models , 2002, Mammalian Genome.

[3]  I. Weinstein.  Addiction to Oncogenes--the Achilles Heal of Cancer , 2002, Science.

[4]  H. Varmus,et al.  Induction of ovarian cancer by defined multiple genetic changes in a mouse model system. , 2002, Cancer cell.

[5]  H. Varmus,et al.  Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. , 2001, Genes & development.

[6]  A. Diez-Juan,et al.  Overexpression of p27Kip1 by doxycycline‐regulated adenoviral vectors inhibits endothelial cell proliferation and migration and impairs angiogenesis , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  J. Yewdell,et al.  Restricting Expression Prolongs Expression of Foreign Genes Introduced into Animals by Retroviruses , 2000, Journal of Virology.

[8]  M. T. Hasan,et al.  Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[9]  H. Varmus,et al.  Development of a flexible and specific gene delivery system for production of murine tumor models , 1999, Oncogene.

[10]  L. Chin,et al.  Essential role for oncogenic Ras in tumour maintenance , 1999, Nature.

[11]  A. Leavitt,et al.  A model for studying megakaryocyte development and biology. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[12]  H. Varmus,et al.  Modeling mutations in the G1 arrest pathway in human gliomas: overexpression of CDK4 but not loss of INK4a-ARF induces hyperploidy in cultured mouse astrocytes. , 1998, Genes & development.

[13]  H. Varmus,et al.  A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice. , 1998, Genes & development.

[14]  S. Hughes,et al.  The EV-O-derived cell line DF-1 supports the efficient replication of avian leukosis-sarcoma viruses and vectors. , 1998, Virology.

[15]  P. Vogt,et al.  The DF-1 chicken fibroblast cell line: transformation induced by diverse oncogenes and cell death resulting from infection by avian leukosis viruses. , 1998, Virology.

[16]  M. Hagiwara,et al.  Controlled gene expression with a reverse tetracycline-regulated retroviral vector (RTRV) system. , 1997, Biochemical and biophysical research communications.

[17]  M. Gossen,et al.  Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[18]  S. Hughes,et al.  Expression of transduced genes in mice generated by infecting blastocysts with avian leukosis virus-based retroviral vectors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[19]  H. Varmus,et al.  A system for tissue-specific gene targeting: transgenic mice susceptible to subgroup A avian leukosis virus-based retroviral vectors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[20]  T. Taniguchi,et al.  Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1 , 1994, Cell.

[21]  R. Weinberg,et al.  Tumor spectrum analysis in p53-mutant mice , 1994, Current Biology.

[22]  K. Kinzler,et al.  The multistep nature of cancer. , 1993, Trends in genetics : TIG.

[23]  S. Ben‐Sasson,et al.  Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation , 1992, The Journal of cell biology.

[24]  E. M. Pantelouris,et al.  Absence of Thymus in a Mouse Mutant , 1968, Nature.